Tissue Engineering Heart Valve Leaflets.
Tissue Engineering Heart Valve Leaflets.
批准号:
14571284
负责人:
MATSUMURA Goki
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Various vascular grafts are commonly used in the reconstruction of cardiovascular tissues. However, currently used prosthetic or bioprosthetic materials lack growth potential and, therefore, subsequently require replacement in pediatric patients as they mature. Tissue engineering (TE) is a new discipline that offers the potential to create replacement structures from autologous cells and biodegradable polymer scaffolds. Because TE constructs contain living cells, they may have the potential to grow, self-repair, and self-remodel. Tissue Engineered Autografts (TEAs) were made by seeding 4-6 x 10^6 of mixed cells obtained from femoral veins of mongrel dogs onto valved patch-shape biodegradable polymer scaffolds composed of a polyglycolic acid (PGA) non-woven fabric sheet and a co-polymer of l-lactide and- caprolactone (N=4). After 7 days, the pulmonary valve leaflet of the same dogs was replaced with TEAs. After 3, 4, 5 and 6 months, angiographies were performed, and the dogs were sacrif … More iced. The implanted TAs were examined both grossly and immunohistologically. The implanted TEAs showed no evidence of stenosis or dilatation. No thrombus was found inside the TEAs, even without any anticoagulation therapy. Remnants of the polymer scaffolds were not observed in all specimens, and the overall gross appearance appeared similar to that of native pulmonary valves. Immunohistological staining revealed the presence of Factor VIII positive nucleated cells at the luminal surface of the TEAs. In addition, lesions were observed where α-smooth muscle actin and desmin positive cells existed. Implanted TEAs contained a sufficient amount of extracellular matrix, and showed neither occlusion nor aneurysmal formation. In addition, endothelial cells were found to line the luminal surface of each TEA. These results strongly suggest that 'ideal' grafts with anti-thrombogenicity can be produced. Because both our laboratory and clinical experiences are quite encouraging, we suggest that the TE approach may play an important role as an alternative method to transplantation and to the use of artificial organs in the field of pediatric cardiovascular surgery. Less
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
新岡俊治: "大口径血管の再生医学"ドクターズマガジン. 2003.2. 40-41 (2003)
新冈俊二:“大直径血管的再生医学”,《医生杂志》2003.2(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
新岡俊治, 松村剛毅, 日比野成俊, 内藤祐次, 小坂由道, 黒澤博身: "骨髄細胞を使用する再生血管移植の臨床"日本内科学会誌. 92. 11776-11780 (2003)
Shunji Niioka、Takeki Matsumura、Shigetoshi Hibino、Yuji Naito、Yumichi Kosaka、Hiroshi Kurosawa:“使用骨髓细胞的临床再生血管移植”日本内科学会杂志 92. 11776-11780 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A Successful Clinical Application of Tissue Engineered Graft for Extracardiac Fontan Operation
组织工程移植物在心外Fontan手术中的成功临床应用
DOI:
--
发表时间:
2002
期刊:
Journal of Thoracic & Cardiovascular Surgery 125
影响因子:
--
作者:
[Naito Y, Imai Y, Shin'oka T, Aoki M, Kashiwagi, Konuma T, Kurosawa H.]
通讯作者:
Kurosawa H.
小坂由道, 新岡俊治: "生体吸収性人工血管の臨床応用"田畑泰彦編ここまで進んだ再生医療の実際. 96-103 (2003)
Yumichi Kosaka、Shunji Niioka:“生物可吸收人造血管的临床应用”,田端泰彦编辑,迄今为止的再生医学进展96-103。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Effects of dilutional and modified ultrafiltration in plasma endothelin-1 and pulmonary vascular resistance after the fontan procedure
稀释和改良超滤对 Fontan 手术后血浆内皮素-1 和肺血管阻力的影响
DOI:
--
发表时间:
2002
期刊:
Ann Thorac Surg 73
影响因子:
--
作者:
[T.Hiramatsu, Y.Imai, H.Kurosawa, Y.Takanashi, M.Aoki, T.Shin'oka]
通讯作者:
T.Shin'oka
共 18 条
Development of Novel Biodegradable Scaffold for Non-Cell-Seeding In-vivo Tissue-Engineering Vasculature for Clinical Applications
-
批准号:23390339
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2011
-
负责人:MATSUMURA Goki
-
依托单位:
Development of Novel Biodegradable Scaffold for Non-Cell-Seeding In-vivo Tissue-Engineering Vasculature and It's Clinical Applications
-
批准号:20390373
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2008
-
负责人:MATSUMURA Goki
-
依托单位:
Clinical Application of Tissue Engineered Vascular Autograft using Autologous Bone Marrow Cells and Biodegradable Scaffolds
-
批准号:18591563
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:MATSUMURA Goki
-
依托单位:
Construction of Tissue-Engineered Vascular Autograft using Bone Marrow Derived Stem Cells and Biodegradable Scaffold and It's Clinical Application
-
批准号:16591415
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2004
-
负责人:MATSUMURA Goki
-
依托单位:
TISSUE ENGINEERING PULMONARY ARTERIES
-
批准号:12671333
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2000
-
负责人:MATSUMURA Goki
-
依托单位:
海外基金